A new report finds that a majority of Americans think the U.S. should be a world leader in science, but Democrats ...
Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots ...
Thermo Fisher Scientific is starting 2026's J.P. Morgan Healthcare Conference with a bang, announcing two new deals with an ...
1don MSN
A big acquisition decades ago almost broke Boston Scientific. Its CEO says this time is different.
Boston Scientific’s last mega-deal didn’t go so well. The medtech company with a large Minnesota presence acquired Arden ...
Artificial intelligence promises to accelerate scientific discovery and open new frontiers of inquiry. But new research from ...
Boston Scientific is purchasing heart-device company Penumbra for roughly $14.5 billion in cash and stock, marking the ...
Scientific uncertainty persists around 3I/ATLAS after anomalous observations and a CIA FOIA response, despite NASA’s public ...
Boston Scientific said on Thursday it will buy Penumbra in a deal valued at about $14.5 billion to expand its vascular ...
With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.
The consequences could be severe. With paylines at most NIH Institutes well below 10 percent, every award not based on merit ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions and laboratory automation at scale. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback